Full Press Release Details
Avista Public Acquisition Corp. II Announces the Separate Trading
of its Class A Ordinary Shares and Warrants, Commencing September 30, 2021
NEW YORK, NY, September 27, 2021 - Avista Public
Acquisition Corp. II (the "Company") announced that commencing September 30, 2021, holders of the units sold in the
Company's initial public offering of 23,000,000 units may elect to separately trade the Class A ordinary shares and warrants
included in the units. Class A ordinary shares and warrants that are separated will trade on the Nasdaq Capital Market ("Nasdaq")
under the symbols "AHPA" and "AHPAW," respectively. Those units not separated will continue to trade on Nasdaq
under the symbol "AHPAU." No fractional warrants will be issued upon separation of the units and only whole warrants will
This press release shall not constitute an offer to sell or the solicitation
of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which
such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state
The offering was made only by means of a prospectus. Copies of the
prospectus may be obtained for free by visiting EDGAR on the SEC's website at www.sec.gov. Alternatively, copies of the prospectus
may be obtained, when available, from Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, 6933 Louis Stephens Drive, Morrisville,
NC 27560, Telephone: 1-800-221-1037, Email: usa.prospectus@credit-suisse.com.
About Avista Public Acquisition Corp. II
Avista Public Acquisition Corp. II is a special purpose acquisition
company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses in the healthcare sector.
Forward-Looking Statements
This press release may include "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. All statements other than statements of historical fact included in this press release are
forward-looking statements. When used in this press release, words such as "anticipate," "believe,"
"estimate," "expect," "intend" and similar expressions, as they relate to us or our management
team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as
assumptions made by, and information currently available to, the Company's management. Actual results could differ materially
from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings
with the Securities and Exchange Commission ("SEC"). All subsequent written or oral forward-looking statements
attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are
subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors
section of the Company's registration statement and prospectus for the Company's initial public offering filed with the
SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except
Amanda Heravi, Investor Relations Officer